Guo, Ming

Login to edit your profile page

Titles

Professor, Neurology

Molecular & Medical Pharmacology

Member, Brain Research Institute

CTSI

Cell & Developmental Biology GPB Home Area

Center for Duchenne Muscular Dystrophy

Center for Neurodegenerative Disease Studies

Molecular, Cellular & Integrative Physiology GPB Home Area

Neuroscience GPB Home Area

themes


Awards and Honors:

UCLA School of Medicine

UCLA School of Medicine

UC Irvine Medical Center

UCLA School of Medicine

Contact Information

Email
mguo@mednet.ucla.edu
Phone
Lab Number: 310-794-4851
Office Phone Number: 310-206-9406
Work Phone Number: (310) 794-1195
Address

Laboratory Address:

Laboratory
Gonda 3309

UNITED STATES

Office Address:

Office
Gonda 3357A

UNITED STATES

Website
http://www.uclahealth.org/MingGuo
http://guolab.neurology.ucla.edu

Biography

Ming Guo, M.D., Ph.D., is P. Gene & Elaine Smith Chair in Alzheimer's Disease Research and Professor at UCLA Department of Neurology, Molecular and Medical Pharmacology. As a practicing Neurologist, she sees patients with memory disorders, neurodegenerative and neurogenetic disorders, referred from both domestic and international sources. As a researcher, her lab investigates molecular mechanisms of the two most common neurodegenerative disorders, Alzheimer’s and Parkinson’s disease. Mutations in PINK1 and PARKIN lead to inherited forms of Parkinson’s disease. Her lab is one of the first two labs worldwide to report the function of PINK1, and to discover that PINK1, a mitochondria-localized serine-threonine kinase, and PARKIN, an E3 ubiquitin ligase, act in a common genetic pathway to regulate mitochondrial integrity and mitochondrial quality control. Her work has wide-range implications for controlling processes in aging, and other aging-related diseases including other neurodegenerative disorders, heart disease and metabolic disorders. Dr. Guo is an elected member of the American Neurological Association (ANA), and has received many awards. She is an Alfred P. Sloan Foundation fellow, a McKnight Neuroscience Foundation Brain Disorder Awardee, an Ellison Medical Foundation Senior Scholar in Aging, a Klingenstein-Simon’s Fellow in Neuroscience, and the Klingenstein-Simon Foundation Robert H. Ebert Clinical Scholar. Her work is also supported by the National Institute of Health (NIH) EUREKA (Exceptional Unconventional Research Enabling Knowledge Acceleration) award. In addition, she was selected to receive the ANA Derek Denny Brown Neurological Scholar Award that is given to one or two awardees each year, and the John Walsh Young Investigator Award, which is given to one Assistant or Associate professor every three years for their research creativity at UCLA. Dr. Guo is actively involved in community service. She is Chair of the Board of Scientific Counselors at the National Institute of Neurological Disorders and Stroke (NIH/NINDS). She also serves as a member of a Blue Ribbon Panel for the NIH/NINDS, the ANA Scientific Program Advisory Committee, the Society of Neuroscience Program Committee, and the Scientific Advisory Committee of the A.P. Giannini Foundation in California.

Publications

Zhang T, Mishra P, Hay BA, Chan D and Guo M   VCP inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants, eLife, 2017; in press: .
Kandul, N.P., Zhang, T., Hay, B.A.*, and Guo, M* (equal contribution).   Selective removal of deletion-bearing mitochondrial DNA in heteroplastic Drosophila, Nature Communications, 2016; in press: .
Harteinstein, V.*, Cruz, L., Lovick, J.K., and Guo, M.* (co-correspondence)   Developmental analysis of the dopamine-containing neurons of the Drosophila brain, Journal of Comparative Neurology, 2016; .
Yun, J., Puri, R.*, Yang, H.*, Lizzio, M., Wu, C., Sheng, Z.H. and Guo, M.   MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin, eLife, 2014; 3(e01958): (equal contribution).
Dauer WT, Guo M.   Multiplying messages LRRK beneath Parkinson disease, Cell, 2014; 157: 291-293.
Dodson, M.W., Leung, L.K., Lone, M. Lizzio, M.A. and Guo, M.   Novel alleles of the Drosophila LRRK2 homolog reveal a crucial role in endolysosomal functions and autophagy in vivo, Disease Models and Mechanisms, 2014; 7:: 1351-63.
Gross GG, Lone GM, Leung LK, Hartenstein V, Guo M.   X11/Mint genes control polarized localization of axonal membrane proteins in vivo, J. Neurosci. , 2013; 33: 8575-8586 (cover story).
Guo, M.   Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease, Cold Spring Harb. Perspect. Med, 2012; a009944: .
M.W. Dodson, T. Zhang, C. Jiang, S. Chen and M. Guo   Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning, Human Molecular Genetics, 2012; 21: 1350-1363.
J.C. Rochet, B.A. Hay and M. Guo   Molecular Insights into Parkinson's Disease, Progress in Molecular Biology and Translational Science, 2012; 107: 125-188.
M. Guo   What have we learned from Drosophila models of Parkinson?s disease, Progress in Brain Research, 2010; 184: 3-17.
B.A. Hay, C.H. Chen, C. M. Ward, H. Huang. J. T.Su, and M. Guo   Engineering the genomes of wild insect populations: Challenges, and opportunities provided by synthetic Medea selfish genetic elements, J. Insect Physiol. , 2010; 56: 1402-1413.
Li, H. and Guo, M.   Protein Degradation in Parkinson Disease Revisited: It's Complex , J. Clinical Invest, 2009; 119: 442-445.
Deng, H. Dodson, M.W. Huang, H. Guo, M.   The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or fusion in Drosophila PNAS, 2008; 105: 14503-14508.
Yun, J. Cao, J.H. Dodson, M.W Clark, I.E. Kapahi, P. Chowdhury, R.B. and Guo, M.   Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the pink1/parkin pathway in vivo J. Neurosci, 2008; 28: 14500-14510.
Gross, G.G. Feldman, R. Ganguly, A. Wang, J. Yu, H. and Guo, M.   Role of X11 and ubiquilin as in vivo regulators of the amyloid precursor protein in Drosophila PLoS ONE, 2008; 3: e2495.
Ganguly, A.*, Feldman, R.* and Guo, M.   ubiquilin antagonizes presenilin and promotes neurodegeneration Human Molecular Genetics, 2008; 17: 293-302. (Cover Story).
Chen, C., Huang, H., Ward, C., Su, J., Schaeffer, L., M. Guo and Hay, B.A.   A Synthetic Maternal-Effect Selfish Genetic Element Drives Population Replacement in Drosophila Science, 2007; 316: 597-600.
Dodson, M.W. and Guo, M.   Pink1, Parkin, DJ-1 and Mitochondrial Dysfunction in Parkinson's Disease Curr. Opin. Neurobiol, 2007; 17: 331-337.
Clark, I.E*., Dodson, M.W.*, Jiang, C.*, Cao, J.H., Huh, J.R., Seol, J.H., Yoo, S.J., Hay, B.A. and Guo, M.   Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin Nature, 2006; 441: 1162-1166.
Hay, B.A. and Guo, M.   Caspase-Dependent Cell Death in Drosophila Annu. Rev. Cell Dev. Biol, 2006; 22: 623-650.
Hay, BA, Huh, JR and Guo, M   The genetics of cell death: approaches, insights and opportunities in Drosophila Nature Review Genetics , 2004; 5(12): 911-22.
Xu P, Guo M, Hay BA.   MicroRNAs and the regulation of cell death, Trends Genet, 2004; 20(12): 617-624.
Guo, M Hong, EJ Fernandes, J Zipursky, SL Hay, BA   A reporter for amyloid precursor protein gamma-secretase activity in Drosophila Human molecular genetics. , 2003; 12(20): 2669-78.
Hay, BA Guo, M   Coupling cell growth, proliferation, and death. Hippo weighs in Developmental cell. , 2003; 5(3): 361-3.
Xu, P Vernooy, SY Guo, M Hay, BA   The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism Current biology : , 2003; 13(9): 790-5.
Guo, M., Hay, B.   Cell proliferation and apoptosis, Curr Opin Cell Biol. , 1999; 11: 745-752.